C12Q 1/527
Involving lyase
Official title: involving lyase
C12Q1/527 (Involving lyase) appears on 264 US grants and 353 published applications in this corpus.
Search patents in C12Q- Granted patents
- 264
- Published applications
- 353
- Assignees
- 244
- Inventors
- 741
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 8 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 7 | 0 |
| 2001 | 8 | 1 |
| 2002 | 10 | 12 |
| 2003 | 7 | 29 |
| 2004 | 10 | 18 |
| 2005 | 11 | 22 |
| 2006 | 4 | 15 |
| 2007 | 7 | 18 |
| 2008 | 10 | 20 |
| 2009 | 6 | 13 |
| 2010 | 11 | 12 |
| 2011 | 6 | 11 |
| 2012 | 6 | 16 |
| 2013 | 4 | 15 |
| 2014 | 19 | 21 |
| 2015 | 10 | 12 |
| 2016 | 12 | 17 |
| 2017 | 9 | 12 |
| 2018 | 6 | 21 |
| 2019 | 17 | 7 |
| 2020 | 14 | 11 |
| 2021 | 6 | 9 |
| 2022 | 4 | 7 |
| 2023 | 6 | 6 |
| 2024 | 10 | 12 |
| 2025 | 2 | 8 |
| 2026 | 4 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Detection of analyte16 Jun 2026US 12,655,459 B2Northwestern University
- Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic26 May 2026US 12,636,353 B2The Regents of the University of California
- Systems and methods for measuring cell signaling protein activity31 Mar 2026US 12,590,959 B2Octant, Inc.
- Bacteria for the treatment of disorders10 Feb 2026US 12,545,886 B2Synlogic Operating Company, Inc.
- Genetically modified bacteria producing three DNA repair enzymes and method for the evaluation of DNA repair activity20 May 2025US 12,305,174 B2Ministerio De Defensa Nacional—Instituto Antartico Uruguayo
- Genetically encoded system for quantifying rubisco activity in catalyzing carbon fixation24 Sep 2026US 2026/0286368 A1The Scripps Research Institute
- Potency assay matrix for neuronal cells24 Sep 2026US 2026/0287576 A1Aspen Neuroscience, Inc.
- Induced Pluripotent Stem Cell Model of Fibrous Dysplasia/Mccune-Albright Syndrome and Methods of Use10 Sep 2026US 2026/0266803 A1The Regents of the University of California
- Method of predicting success of a cancer therapy13 Aug 2026US 2026/0235610 A1Immusmol SAS
- Apparatus and methods using coupled enzyme luminescence assays for the detection of analytes and biomarkers2 Jul 2026US 2026/0185138 A1TETmedical, Inc.
Most cited
By later US patents
- Enzymatic fluorometric assay for adenylate cyclase65US 5,618,665 ARegents of the University of Minnesota · 1997
- Enzymatic fluorometric assay for adenylate cyclase59US 5,316,907 ARegents of the University of Minnesota · 1994
- Pharmaceutical compositions containing chondroitinase and uses therefor49US 6,200,564 B12001
- Heparinase III and uses thereof45US 6,869,789 B2Massachusetts Institute of Technology · 2005
- Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe39US 6,190,875 B1Hadasit Medical Research and Development Ltd. · 2001